Ocugen, Inc. Operating Income Loss

Quick Answer

Ocugen, Inc. reported Operating Income Loss of -$62.92 million for the year ending 2025.

  • Ocugen, Inc. showed a decrease of -14.9% in Operating Income Loss from 2024 to 2025.
  • This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: -$5.17 million | Q2 2014: -$6.01 million | Q3 2014: -$14.94 million | Q1 2015: -$7.87 million | Q2 2015: -$7.59 million | Q3 2015: -$8.04 million | Q1 2016: -$7.80 million | Q2 2016: -$7.96 million | Q3 2016: -$6.65 million | Q1 2017: -$6.83 million | Q2 2017: -$6.37 million | Q3 2017: -$5.71 million | Q1 2018: -$6.09 million | Q2 2018: -$7.28 million | Q3 2018: -$2.40 million | Q1 2019: -$4.84 million | Q2 2019: -$2.33 million | Q3 2019: -$2.71 million | Q1 2020: -$3.93 million | Q2 2020: -$3.37 million | Q3 2020: -$10.18 million | Q1 2021: -$7.06 million | Q2 2021: -$25.61 million | Q3 2021: -$10.79 million | Q1 2022: -$19.03 million | Q2 2022: -$21.58 million | Q3 2022: -$25.11 million | Q1 2023: -$18.04 million | Q2 2023: -$23.54 million | Q3 2023: -$12.43 million | Q1 2024: -$12.22 million | Q2 2024: -$15.45 million | Q3 2024: -$13.25 million | Q1 2025: -$14.50 million | Q2 2025: -$13.80 million | Q3 2025: -$17.63 million.
  • Over the full 12 years of available data (2014 to 2025), Ocugen, Inc.'s Operating Income Loss has declined by 92.6%.
  • Historical annual values: Fiscal year 2025: -$62.92 million | Fiscal year 2024: -$54.76 million | Fiscal year 2023: -$65.53 million | Fiscal year 2022: -$89.07 million | Fiscal year 2021: -$58.03 million | Fiscal year 2020: -$21.29 million | Fiscal year 2019: -$14.16 million | Fiscal year 2018: -$16.14 million | Fiscal year 2017: -$24.95 million | Fiscal year 2016: -$30.31 million | Fiscal year 2015: -$31.82 million | Fiscal year 2014: -$32.66 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: